Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: A multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial
Titel:
Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: A multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial
Auteur:
Välimäiki, Matti J. Farrerons-Minguella, Jordi Halse, Johan Kröger, Heikki Maroni, Marilyn Mulder, Henk Muñoz-Torres, Manuel Sääf, Maria Snorre Øfjord, Erik